489 related articles for article (PubMed ID: 28380308)
21. Longitudinal decline of diffusing capacity of the lung for carbon monoxide in community subjects with the PiMZ alpha1-antitrypsin phenotype.
Silva GE; Guerra S; Keim S; Barbee RA; Sherrill DL
Chest; 2008 May; 133(5):1095-100. PubMed ID: 18263681
[TBL] [Abstract][Full Text] [Related]
22. IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency.
Demeo DL; Campbell EJ; Barker AF; Brantly ML; Eden E; McElvaney NG; Rennard SI; Sandhaus RA; Stocks JM; Stoller JK; Strange C; Turino G; Silverman EK
Am J Respir Cell Mol Biol; 2008 Jan; 38(1):114-20. PubMed ID: 17690329
[TBL] [Abstract][Full Text] [Related]
23. Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening.
de Serres FJ; Blanco I; Fernández-Bustillo E
COPD; 2006 Aug; 3(3):133-9. PubMed ID: 17240615
[TBL] [Abstract][Full Text] [Related]
24. A longitudinal study of alpha1-antitrypsin phenotypes and decline in FEV1 in a community population.
Silva GE; Sherrill DL; Guerra S; Barbee RA
Chest; 2003 May; 123(5):1435-40. PubMed ID: 12740258
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the Small Airways in Patients with Chronic Obstructive Pulmonary Disease and Alpha-1 Antitrypsin Deficiency.
Ferrari da Cruz T; Rufino R; Lopes AJ; Noronha A; Medeiros Anselmo F; Henrique da Costa C
Int J Chron Obstruct Pulmon Dis; 2020; 15():2267-2274. PubMed ID: 33061344
[TBL] [Abstract][Full Text] [Related]
26. α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts.
Sørheim IC; Bakke P; Gulsvik A; Pillai SG; Johannessen A; Gaarder PI; Campbell EJ; Agustí A; Calverley PM; Donner CF; Make BJ; Rennard SI; Vestbo J; Wouters EF; Paré PD; Levy RD; Coxson HO; Lomas DA; Hersh CP; Silverman EK
Chest; 2010 Nov; 138(5):1125-32. PubMed ID: 20595457
[TBL] [Abstract][Full Text] [Related]
27. The prevalence of PI*S and PI*Z SERPINA1 alleles in healthy individuals and COPD patients in Saudi Arabia: A case-control study.
Al-Jameil N; Hassan AA; Hassanato R; Isac SR; Otaiby MA; Al-Shareef F; Al-Maarik B; Ajeyan IA; Al-Bahloul K; Ghani S; Al-Torbak D
Medicine (Baltimore); 2017 Oct; 96(42):e8320. PubMed ID: 29049242
[TBL] [Abstract][Full Text] [Related]
28. Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits.
Silverman EK; Province MA; Campbell EJ; Pierce JA; Rao DC
Genet Epidemiol; 1992; 9(5):317-31. PubMed ID: 1427021
[TBL] [Abstract][Full Text] [Related]
29. Exhaled nitric oxide levels in alpha-1-antitrypsin PiMZ subjects.
Malerba M; Ragnoli B; Radaeli A
J Intern Med; 2009 Mar; 265(3):382-7. PubMed ID: 19019191
[TBL] [Abstract][Full Text] [Related]
30. Effects of smoking and intermediate alpha 1-antitrypsin deficiency (PiMZ) on lung function.
Eriksson S; Lindell SE; Wiberg R
Eur J Respir Dis; 1985 Oct; 67(4):279-85. PubMed ID: 3878302
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide association study of lung function and clinical implication in heavy smokers.
Li X; Ortega VE; Ampleford EJ; Graham Barr R; Christenson SA; Cooper CB; Couper D; Dransfield MT; Han MLK; Hansel NN; Hoffman EA; Kanner RE; Kleerup EC; Martinez FJ; Paine R; Woodruff PG; Hawkins GA; Bleecker ER; Meyers DA;
BMC Med Genet; 2018 Aug; 19(1):134. PubMed ID: 30068317
[TBL] [Abstract][Full Text] [Related]
32. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study.
Foreman MG; Zhang L; Murphy J; Hansel NN; Make B; Hokanson JE; Washko G; Regan EA; Crapo JD; Silverman EK; DeMeo DL;
Am J Respir Crit Care Med; 2011 Aug; 184(4):414-20. PubMed ID: 21562134
[TBL] [Abstract][Full Text] [Related]
33. Frequency of Rare Alpha-1 Antitrypsin Variants in Polish Patients with Chronic Respiratory Disorders.
Duk K; Zdral A; Szumna B; Roży A; Chorostowska-Wynimko J
Adv Exp Med Biol; 2016; 910():47-53. PubMed ID: 26987331
[TBL] [Abstract][Full Text] [Related]
34. Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.
Silverman EK; Pierce JA; Province MA; Rao DC; Campbell EJ
Ann Intern Med; 1989 Dec; 111(12):982-91. PubMed ID: 2596778
[TBL] [Abstract][Full Text] [Related]
35. Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency.
Franciosi AN; Hobbs BD; McElvaney OJ; Molloy K; Hersh C; Clarke L; Gunaratnam C; Silverman EK; Carroll TP; McElvaney NG
Am J Respir Crit Care Med; 2020 Jul; 202(1):73-82. PubMed ID: 32197047
[No Abstract] [Full Text] [Related]
36. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry.
Miravitlles M; Turner AM; Torres-Duran M; Tanash H; Rodríguez-García C; López-Campos JL; Chlumsky J; Guimaraes C; Rodríguez-Hermosa JL; Corsico A; Martinez-González C; Hernández-Pérez JM; Bustamante A; Parr DG; Casas-Maldonado F; Hecimovic A; Janssens W; Lara B; Barrecheguren M; González C; Stolk J; Esquinas C; Clarenbach CF
Respir Res; 2022 Dec; 23(1):352. PubMed ID: 36527073
[TBL] [Abstract][Full Text] [Related]
37. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis.
Silverman EK; Chapman HA; Drazen JM; Weiss ST; Rosner B; Campbell EJ; O'DONNELL WJ; Reilly JJ; Ginns L; Mentzer S; Wain J; Speizer FE
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1770-8. PubMed ID: 9620904
[TBL] [Abstract][Full Text] [Related]
38. Reconsidering the Utility of Race-Specific Lung Function Prediction Equations.
Baugh AD; Shiboski S; Hansel NN; Ortega V; Barjaktarevic I; Barr RG; Bowler R; Comellas AP; Cooper CB; Couper D; Criner G; Curtis JL; Dransfield M; Ejike C; Han MK; Hoffman E; Krishnan J; Krishnan JA; Mannino D; Paine R; Parekh T; Peters S; Putcha N; Rennard S; Thakur N; Woodruff PG
Am J Respir Crit Care Med; 2022 Apr; 205(7):819-829. PubMed ID: 34913855
[No Abstract] [Full Text] [Related]
39. SERPINA1 11478G→A variant, serum α1-antitrypsin, exacerbation frequency and FEV1 decline in COPD.
Quint JK; Donaldson GC; Kumari M; Talmud PJ; Hurst JR
Thorax; 2011 May; 66(5):418-24. PubMed ID: 21335450
[TBL] [Abstract][Full Text] [Related]
40. Granularity of
Gupta N; Gaudreault N; Thériault S; Li PZ; Henry C; Kirby M; Maltais F; Tan W; Bourbeau J; Bossé Y;
Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32482783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
